Work

E3303: A Phase II Study of Cetuximab (C225) in Combination with Cisplatin (DDP) and Definitive Radiation (XRT) in Unresectable Squamous Cell Carcinoma of the Head and Neck (U-SCCHN)

Year: 2009

Type: conference-abstract

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2009.07.058

Authors: H. Quon, C.J. Langer, J. Lee, U.A. Patel, D.M. Shin, A. Argiris, J.A. Ridge, A.A. Forastiere

Institutions: University of Pennsylvania, Dana-Farber Cancer Institute, John H. Stroger, Jr. Hospital of Cook County, Emory University, University of Pittsburgh, Fox Chase Cancer Center, Johns Hopkins University

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2051580791

Cites:

Cited by: 4

Related to: 10